Adverse responses: sedation, analgesia and neuromuscular blocking agents in critically ill children

Lauren R Sorce1

  • 1Pediatric Critical Care, Children's Memorial Hospital, 2300 Children's Plaza Box 246, Chicago, IL 60614, USA. lsorce@childrensmemorial.org

Insights

Advanced practice nurses (APNs) manage critically ill children with sedation and analgesia. This article details adverse drug reactions, such as withdrawal and muscle weakness, to help APNs prevent harm.

Area of Science:

  • Pediatric Critical Care
  • Pharmacology
  • Nursing Practice

Background:

  • Advanced practice nurses (APNs) play a crucial role in managing critically ill pediatric patients.
  • Sedation, analgesia, and neuromuscular blocking agents are commonly prescribed by APNs for these patients.
  • While generally safe, these medications can cause adverse events in children.

Purpose of the Study:

  • To inform APNs about potential adverse responses to sedation, analgesia, and neuromuscular blocking agents in critically ill children.
  • To highlight specific morbidities associated with these medications.
  • To provide guidance for APN practice in managing these adverse events.

Main Methods:

  • Literature review and synthesis of existing data on adverse drug reactions.
  • Clinical case examples (implied).
  • Analysis of associated morbidities and costs.

Main Results:

  • Identified adverse responses include withdrawal syndrome, muscle weakness, decreased gastric motility, and corneal abrasions.
  • These adverse events can lead to significant patient morbidity.
  • Associated healthcare costs are an important consideration.

Conclusions:

  • APNs must be aware of and vigilant for adverse responses to commonly prescribed medications in critically ill children.
  • Early recognition and management of these adverse events are essential to minimize patient harm.
  • Understanding the spectrum of adverse effects and their associated costs is vital for optimizing pediatric critical care.

Related Concept Videos

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.